Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Boston Scientific Corporation

Boston Scientific Corporation (BSX) Stock Overview

Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.

BSX●NYSE
HealthcareMedical - Devices
$51.69
$0.27(0.53%)
U.S. Market opens in 3h 2m

Boston Scientific Corporation (BSX)

Meyka AI Score

Z

Key Financials

Market Cap76.9B
P/E Ratio20.91
EPS (TTM)$3.10
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$49.64
3 Months$23.21
1 Year Target$27.38

BSX Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Boston Scientific Corporation (NYSE: BSX) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Boston Scientific Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BSX on the NYSE shows an RSI of 72.68, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $27.38 for the NYSE listing.

Key metrics behind Boston Scientific Corporation's NYSE-traded stock include a P/E ratio of 20.91 and a market capitalization of 76.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BSX on the NYSE.

Price Performance (NYSE: BSX)

1-Day Change
0.57%
5-Day Change
4.47%
1-Month Change
15.82%
3-Month Change
-2.53%
6-Month Change
-30.80%
Year-to-Date (YTD) Change
-45.76%
1-Year Change
-49.55%
3-Year Change
0.75%
5-Year Change
16.66%
All-Time (Max) Change
1107.94%

Contact Information

https://www.bostonscientific.com
508 683 4000
300 Boston Scientific Way, Marlborough, MA, 01752-1234

Company Facts

590,000 Employees
IPO DateMay 19, 1992
CountryUS
Actively Trading

Frequently Asked Questions